Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03667573 · ClinicalTrials.gov registry record · Phase 1
Spinal Excitation to Enhance Mobility
A Phase 1 study, sponsored by VA Office of Research and Development.
- Completed
- Registry status
- Phase 1
- Development phase
- 23
- Enrollment target
NCT03667573: Completed Phase 1 study, sponsored by VA Office of Research and Development.
NCT03667573 is a Phase 1 study that has completed, run by VA Office of Research and Development. The registered enrollment target is 23 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03667573, a Phase 1 study, has completed, sponsored by VA Office of Research and Development.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 23 participants
- Enrollment target
Study Summary
Older adults with compromised walking ability have higher rates of morbidity and mortality, more hospitalizations, poorer quality of life, and are less likely to remain independent in the community. It is known that age-related changes in brain and peripheral nerves contribute to loss of walking ability. However, there is a lack of research into how the aging spinal cord affects walking. In older adults, the spinal cord is less excitable, conducts signals more slowly, and is subject to neural noise. Intervening on age-related impairment of the spinal cord to improve walking ability is a very promising but untapped area of research.
Interventions
- DEVICE tsDCS Dosage (A)
- DEVICE tsDCS Dosage (B)
- OTHER textured shoe insoles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2018-12-17 |
| Est. Completion | 2021-08-18 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03667573
The ClinicalTrials.gov registry entry for NCT03667573 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is VA Office of Research and Development, which has 1,668 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which tsDCS Dosage (A) is the first listed.
NCT03667573 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03667573 about?
NCT03667573 is a clinical study titled "Spinal Excitation to Enhance Mobility". Older adults with compromised walking ability have higher rates of morbidity and mortality, more hospitalizations, poorer quality of life, and are less likely to remain independent in the community. It is known that age-related changes in brain and peripheral nerves contribute to loss of walking abi...
What is the current status of trial NCT03667573?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 23 participants. The study started on 2018-12-17. Estimated completion is 2021-08-18.
What interventions are being tested in trial NCT03667573?
The interventions under investigation include: tsDCS Dosage (A) (DEVICE), tsDCS Dosage (B) (DEVICE), textured shoe insoles (OTHER).
Who is sponsoring clinical trial NCT03667573?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.